产品编号 | CFN60007 | |
CAS编号 | 1257044-40-8 | |
分子式 = 分子量 | C45H50ClN7O7S = 868.4 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Alkaloids | |
植物来源 | ||
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
维纳妥拉(ABT-199) | CFN60007 | 1257044-40-8 | 1mg | QQ客服:2056216494 |
维纳妥拉(ABT-199) | CFN60007 | 1257044-40-8 | 5mg | QQ客服:2056216494 |
维纳妥拉(ABT-199) | CFN60007 | 1257044-40-8 | 10mg | QQ客服:2056216494 |
维纳妥拉(ABT-199) | CFN60007 | 1257044-40-8 | 20mg | QQ客服:2056216494 |
Description: | Venetoclax (ABT-199, GDC-0199) is a Bcl-2-selective inhibitor with Ki of <0.01 nM in cell-free assays, >4800-fold more selective versus Bcl-xL and Bcl-w, and no activity to Mcl-1. Venetoclax is reported to induce cell growth suppression, apoptosis, cell cycle arrest, and autophagy in triple negative breast cancer MDA-MB-231 cells. |
Targets: | Bcl-2 | Bcl-xL | Bcl-w | Autophagy |
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.1515 mL | 5.7577 mL | 11.5154 mL | 23.0309 mL | 28.7886 mL |
5 mM | 0.2303 mL | 1.1515 mL | 2.3031 mL | 4.6062 mL | 5.7577 mL |
10 mM | 0.1152 mL | 0.5758 mL | 1.1515 mL | 2.3031 mL | 2.8789 mL |
50 mM | 0.023 mL | 0.1152 mL | 0.2303 mL | 0.4606 mL | 0.5758 mL |
100 mM | 0.0115 mL | 0.0576 mL | 0.1152 mL | 0.2303 mL | 0.2879 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
24,25-二羟基达马树脂-20-烯-3-酮; 24,25-Dihydroxydammar-20-en-3-one | CFN97093 | 63543-53-3 | C30H50O3 = 458.7 | 5mg | QQ客服:1413575084 |
松萝酸; Usnic acid | CFN97236 | 7562-61-0 | C18H16O7 = 344.3 | 20mg | QQ客服:3257982914 |
Spiratisanin C; Spiratisanin C | CFN96667 | 1902173-22-1 | C29H40O3 = 436.63 | 5mg | QQ客服:2159513211 |
马兜铃内酰胺BII; Aristolactam BII | CFN98903 | 53948-09-7 | C17H13NO3 = 279.3 | 5mg | QQ客服:1413575084 |